Best Possible Medication Historybpmh@USBNCT03851328
Best Possible Medication History at USB
An observational study of Best Possible Medication History, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.
Trial summary
This pilot project investigates the use of a structured medication history (Best Possible Medication History, BPMH) in patients (primarily admitted at the emergency department of University Hospital Basel) after transfer to a medical ward. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Best Possible Medication History
- What is being tested?
- BPMH structured interview
- How many people
- 160 participants
- Where
- 1 siteSwitzerland
- Study dates
- 1 Sep 2017to 30 Dec 2019
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Patients admitted to Emergency Department of University Hospital Basel and being transfered to medical ward
Who may be able to join
- Admission to Emergency Department of University Hospital Basel and transfer to medical ward
Who cannot join
- medication history taken at Emergency Department of University Hospital Basel not present
Trial locations and contacts
1 site in 1 country.
Switzerland1 site
Spitalpharmazie Universitätsspital Basel (USB)
Basel, 4031
About this study
Official title: Best Possible Medication History at Universitätsspital Basel (USB)
This pilot project investigates the use of a structured medication history (Best Possible Medication History, BPMH) in patients (primarily admitted at the emergency department of University Hospital Basel) after transfer to a medical ward. Unintentional medication discrepancies are analyzed comparing outpatient and inpatient medication therapy.
- Conditions
- Best Possible Medication History
- Being tested
- BPMH structured interview
- Keywords
- Adverse Drug Events (ADEs), Medication Accuracy, Medication Discrepancy
- Medical subject headings
- Drug-Related Side Effects and Adverse Reactions
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
BPMH structured interviewOther
creating a standardized medication list by interviewing patient and/ or relatives according to Best Possible Medication History (BPMH) after patient transfer to medical ward
What is being measured
The primary outcome is the main question the study is designed to answer.
unintended medication discrepancy
number of unintended medication discrepancies comparing medication history taken when admitted to emergency department and BPMH after transfer to medical ward
Measured: single time point (1 day after admission to hospital)
Secondary outcomes (1)
Categorisation ( Class1, Class2, Class3) for clinical relevance of unintended medication discrepancy
expert panel classifies each unintended medication discrepancy in 1 of 3 classes for its potential to cause patient harm. Class 1 discrepancies are those unlikely to cause patient discomfort or clinical deterioration. Class 2 discrepancies could potentially result in moderate discomfort or clinical deterioration. Class 3 discrepancies could potentially result in severe discomfort or clinical deterioration.
Measured: during 7 days after admission to hospital
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Feb 2019
- Study start1 Sep 2017
- Primary completion31 Oct 2017
- Study completion30 Dec 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Best Possible Medication HistoryStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 160 participants (actual)
Sponsor and investigators
- Lead sponsor
- University Hospital, Basel, Switzerland
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Stephan Gut, Principal investigator, Spitalpharmazie Universitätsspital Basel (USB)
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03851328
- Sponsor's protocol ID
- 2017-00575; qu17Gut
- Other IDs
- 2017
- Acronym
- bpmh@USB
- Status last verified
- May 2020
- First submitted
- 12 Feb 2019
- Last updated
- 6 May 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 6 May 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Best Possible Medication History at Universitätsspital Basel (USB)
- ClinicalTrials.gov ID
- NCT03851328
- Acronym / sponsor ID
- bpmh@USB / 2017-00575; qu17Gut
- Conditions
- Best Possible Medication History
- Keywords
- Adverse Drug Events (ADEs), Medication Accuracy, Medication Discrepancy
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 160 participants (actual)
- Lead sponsor
- University Hospital, Basel, SwitzerlandUniversity, hospital or other
- Study start
- 1 Sep 2017 (actual)
- Primary completion
- 31 Oct 2017 (actual)
- Study completion
- 30 Dec 2019 (actual)
- First posted
- 22 Feb 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This pilot project investigates the use of a structured medication history (Best Possible Medication History, BPMH) in patients (primarily admitted at the emergency department of University Hospital Basel) after transfer to a medical ward. Unintentional medication discrepancies are analyzed comparing outpatient and inpatient medication therapy.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Patients admitted to Emergency Department of University Hospital Basel and being transfered to medical ward
Key inclusion criteria (1 listed)
- Admission to Emergency Department of University Hospital Basel and transfer to medical ward
Key exclusion criteria (1 listed)
- medication history taken at Emergency Department of University Hospital Basel not present
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| BPMH structured interviewcreating a standardized medication list by interviewing patient and/ or relatives according to Best Possible Medication History (BPMH) after patient transfer to medical ward | Other | – |
Primary outcome
unintended medication discrepancy
Time frame: single time point (1 day after admission to hospital)
number of unintended medication discrepancies comparing medication history taken when admitted to emergency department and BPMH after transfer to medical ward
1 secondary outcome
Categorisation ( Class1, Class2, Class3) for clinical relevance of unintended medication discrepancy
Time frame: during 7 days after admission to hospital
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 6 May 2020.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Stephan Gut principal investigator
Spitalpharmazie Universitätsspital Basel (USB)
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Best Possible Medication History, run by University Hospital, Basel, Switzerland at 1 site in Switzerland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 6 May 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
unintended medication discrepancy (time frame: single time point (1 day after admission to hospital)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2020.